In contrast to JAK2-wild cancers, the TMB in JAK2-mutated cancers was remarkably greater in the discovery cohort (P = 0.0012, Fig. 2A) and within the verification cohort (P < 0.001, Fig. 2B). The gene discussed is JAK2; the disease is cancer.